Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma

Digestion

Volumn 59, Issue SUPPL. 2, 1998, Pages 89-91

  Muto, Yasutoshi ^a   Moriwaki, Hisataka ^a   Shiratori, Yoshimune ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

fetoprotein; Apoptosis; Cancer chemoprevention; Clonal deletion; Differentiation induction; Hepatocellular carcinoma; Retinoid

Indexed keywords

POLYPRENOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL DIFFERENTIATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG METABOLISM; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASMS, SECOND PRIMARY; TRETINOIN;

EID: 0031853840     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051435     Document Type: Conference Paper

References (12)

1. Muto Y, Omori M, Sugawara K: Demonstration of a novel cellular retinol-binding protein, F-type, in hepatocellular carcinoma. Jpn J Cancer Res (GANN) 1979;70:215-222.
2. Muto Y, Moriwaki H: Antitumor activities of vitamin A and its derivatives. J Natl Cancer Inst 1984;73:1389-1393.
3. Matsushima-Nishiwaki R, Shidoji Y, Nishiwaki S, Yamada T, Moriwaki H, Muto Y: Aberrant metabolism of retinoid X receptor proteins in human hepatocellular carcinoma. Mol Cell Endocrinol 1996;121:179-190.
4. Muto Y, Moriwaki H, Omori M: In vitro binding affinity of novel synthetic polyprenoids (polyprenoic acids) to cellular retinoid-binding proteins. Jpn J Cancer Res (GANN) 1981;72: 974-977.
5. Yamada Y, Shidoji Y, Fukutomi Y, Ishikawa T, Kaneko T, Nakagama H, Imawari M, Moriwaki H, Muto Y: Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines. Mol Carcinog 1994;10:151-158.
6. Nakamura N, Shidoji Y, Yamada Y, Hatakeyama H, Moriwaki H, Muto Y: Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7. Biochem Biophys Res Commun 1995;207:382-388.
7. Nakamura N, Shidoji Y, Moriwaki H, Muto Y: Apoptosis in human hepatoma cell line by 4,5-didehydrogeranylgeranoic acid (acyclic retinoid) via downregulation of transforming growth factor-alpha. Biochem Biophys Res Commun 1996;219:100-104.
8. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T: Prevention of second primary tumors by an acyclic retionid, polyprenoic acid, in patients with hepatocelluar carcinoma. N Engl J Med 1996;334:1561-1567.
9. Moriwaki H, Yasuda I, Shiratori Y, Uematsu T, Okuno M, Muto Y: Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: A potent biomaker in the chemoprevention of second primary hepatoma. Clin Cancer Res 1997;3:727-731.
10. Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekiya C, Igarashi K, Ichida F: The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988;61:769-774.
11. Shiraki K, Takase K, Tameda Y, Hamada M, Kosaka Y, Nakano T: A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 1995;22:802-807.
12. Yamashita F, Tanaka M, Satomura S, Tanikawa K: Prognostic value of lens culinaris agglutinin-A-reactive alpha-fetoprotein in patients with hepatocellular carcinoma. Gastroenterology 1996; 111:996-1001.